{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:25:39Z","timestamp":1790141139101,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Sleep Medicine"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.5664\/jcsm.9006","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T14:09:54Z","timestamp":1606140594000},"page":"711-717","source":"Crossref","is-referenced-by-count":9,"title":["Clinically relevant effects of solriamfetol on excessive daytime sleepiness: a posthoc analysis of the magnitude of change in clinical trials in adults with narcolepsy or obstructive sleep apnea"],"prefix":"10.1007","volume":"17","author":[{"given":"Russell","family":"Rosenberg","sequence":"first","affiliation":[{"name":"NeuroTrials Research, Inc., Atlanta, Georgia"},{"name":"Atlanta School of Sleep Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Baladi","sequence":"additional","affiliation":[{"name":"Jazz Pharmaceuticals, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Bron","sequence":"additional","affiliation":[{"name":"Jazz Pharmaceuticals, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"e_1_3_3_2_2","volume-title":"International Classification of Sleep Disorders","author":"American Academy of Sleep Medicine","year":"2014","unstructured":"American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.","edition":"3"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199304293281704"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/30.6.711"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00124708"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00016808"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/34.1.111"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2006.10.010"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.7624"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.5665\/sleep.5834"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2010.07.010"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12039"},{"key":"e_1_3_3_13_2","unstructured":"Provigil. Package insert. Teva Pharmaceuticals Inc; 2018."},{"key":"e_1_3_3_14_2","unstructured":"Nuvigil. Package insert. Teva Pharmaceuticals Inc; 2018."},{"key":"e_1_3_3_15_2","unstructured":"Wakix. Package insert. Harmony Biosciences; 2019."},{"key":"e_1_3_3_16_2","unstructured":"Ritalin. Package insert. Novartis Pharmaceuticals Corporation; 2019."},{"key":"e_1_3_3_17_2","unstructured":"Xyrem (sodium oxybate) oral solution. Prescribing information. Jazz Pharmaceuticals Inc.; 2018. Accessed December 1 2020. https:\/\/pp.jazzpharma.com\/pi\/xyrem.en.USPI.pdf."},{"issue":"5","key":"e_1_3_3_18_2","first-page":"233","article-title":"The medical and economic burden of narcolepsy: implications for managed care","volume":"10","author":"Thorpy MJ","year":"2017","unstructured":"Thorpy MJ, Hiller G. The medical and economic burden of narcolepsy: implications for managed care. Am Health Drug Benefits. 2017;10(5):233\u2013241.","journal-title":"Am Health Drug Benefits"},{"key":"e_1_3_3_19_2","volume-title":"Sunosi (solriamfetol) tablets. Prescribing information","year":"2019","unstructured":"Sunosi (solriamfetol) tablets. Prescribing information. Jazz Pharmaceuticals, Inc.; 2019. Accessed December 1, 2020. https:\/\/pp.jazzpharma.com\/pi\/sunosi.en.USPI.pdf."},{"key":"e_1_3_3_20_2","volume-title":"Sunosi (solriamfetol) tablets. Summary of product characteristics","year":"2020","unstructured":"Sunosi (solriamfetol) tablets. Summary of product characteristics. Jazz Pharmaceuticals Ireland Ltd.; 2020. Accessed December 1, 2020. https:\/\/ec.europa.eu\/transparency\/regdoc\/rep\/3\/2020\/EN\/C-2020-324-F1-EN-ANNEX-1-PART-1.PDF."},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25423"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201806-1100OC"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/14.6.540"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/20.10.844"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2017.07.006"},{"key":"e_1_3_3_26_2","doi-asserted-by":"crossref","unstructured":"Lammers GJ Bogan R Schweitzer PK et al. Thresholds for clinically meaningful changes on the Epworth Sleepiness Scale and Maintenance of Wakefulness Test sleep latency. Abstract presented at: Biennial World Sleep Congress; September 20\u201325 2019; Vancouver British Columbia Canada.","DOI":"10.1016\/j.sleep.2019.11.587"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X100050"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)30333-7"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/28.4.464"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201907-1284OC"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsaa056.747"}],"container-title":["Journal of Clinical Sleep Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:16:00Z","timestamp":1770110160000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.5664\/jcsm.9006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.5664\/jcsm.9006"],"URL":"https:\/\/doi.org\/10.5664\/jcsm.9006","relation":{},"ISSN":["1550-9389","1550-9397"],"issn-type":[{"value":"1550-9389","type":"print"},{"value":"1550-9397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}